In a recent paper, Henrique-Neto et al. [251] reported the results of a longitudinal study that included 70 adult SS patients with a severe SS profile who received autologous HSCs at a mean dose of 5.63 (3.21) × 106 CD34+ cells/kg body weight. The gene discussed is CD34; the disease is synovial sarcoma.